Clinical Trial: A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07628933) titled 'A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke' on May 22.

Brief Summary: Study Methods: The trial consists of two phases, both including a placebo control.

Phase Ia (single-dose, dose-escalation): Three dose groups (low, medium, high) are set. This is a multicenter, randomized, double-blind, placebo-controlled, single-dose, dose-escalation trial. Dose escalation to the next level is permitted only after safety assessment at 28 days post-dose in the previous group.

Phase Ib (multiple-dose): Based on Phase Ia results, two dose groups will be selected. The product is administered on Day 0, Day 7...